Thymectomy for Myasthenia Gravis at Hospital Dr. Rafael. A. Calderon Guardia

Authors

  • Jose A. Mainieri Hidalgo Caja Costarricense del Seguro Social, Hospital Dr. Rafael A. Calderón Guardia
  • Ivannia Lépiz Cordero Caja Costarricense del Seguro Social, Clínica de Bataán

DOI:

https://doi.org/10.51481/amc.v42i2.566

Keywords:

Timectomía, Myasthenia Gravis

Abstract

Background: Miastenia gravis is an autoimmune disease, its etiology has not been defined clearly. The improvement of the clinical manifestations after thymectomy was first described in 1912; and this procedure has become in one of the therapeutic alternatives for the disease nowadays. The aim of the present study was to investigate the results of thymectomy for miastenia gravis in the Hospital Dr. R. A. Calderón Guardia.

Materials and Methods: Retrospective study, based in the revision of the clinical files of 24 consecutive patients in whom a thymectomy was performed as part of their treatment for miastenia gravis between January 1992 and May 1999 in the Hospital Dr. R. A. Calderon Guardia.

Results: 75% of the patients improved their condition after the surgery, 17% had no variation and 8% deteriorated their

clinical condition after the thymectomy. There was no difference in the clinical outcome related to sex, age or presence of thymoma. However, patients that only had ocular manifestations previous to the surgery had a tendency to remain symp-tomatic after surgery. The pre-surgical preparation of the patient with intravenous gamma globulin and the improvements in the anesthetic technique lowered the need for mechanical ventilation.

Conclusion: Thymectomy improved 75% of the patients with miastenia gravis, specially those who had other manifestations apart from ocular involvement. The procedure allowed the reduction of treatment in 12 of the 24 cases studied.

Downloads

Download data is not yet available.

References

Pascuzzi R. The history of myasthenia gravis. Neurologic Clinics of North America. 1994; 12 231-242.

Engel A, Lambert E, Howard F. Immune complexes (IGG and C3) at the motor end plate in myasthenia gravis: ultrastructural and ligth microscopic localization and electrophysiological correlations. Mayo Clin Proc. 1977; 52: 267-280.

Lindstrom J. Antibody to acethilcholine receptor in Myasthenia Gravis:

prevalence clinical correlates, and diagnostic value. Neurology. 1976;

Toyka K, Drachman B, Pestronk A. Myastenia gravis. Passive transfer

from man to mouse. Science, 1975; 190:397.

Rowland L. Diseases of chemical transmicion at the nerve muscle synapse: myastenia gravis. Kandel ER. Schwartz JH. Jessel TM. editores. Principles of neural science. 3 era. Ediciön: Nueva York. 1991 : 235243.

Monden Y, Uyama T, Taniki T. et al. The characteristics of thymoma with myasthenia gravis: a 28 year experience. J of Surg Oncol 1988; 38:151-154.

Thorvinger. B. Lyttkens, K. Samuelsoon, L. Computed Thomography of the thymus gland in myasthenia gravis. Acta Radiolögica. 1987; 28(4): 399-401.

Ellis K, Austin J, Jaretzki A. Radiologic detection of thymoma in patients with myasthenia gravis. AJR. 1988; 151: 873-881.

Nicolaou S, Muller N, Li D, Oger J. Thymus in myasthenia gravis: comparison of CT and pathologic findings and clinical outcome after thymectomy. Radiology. 1996; 201 :471-474.

Martinez J, Mariscal A. Tratamiento de la miastenia grave. Medicina Clinica 1993; 101(18).

Haberer, H. Zur Klinischen bedeutung der thymusdruse. Arch Clin Chir. 1917; 109:193-249.

Blalock A. Thymectomy in the treatment of myasthenia gravis: Repott of 20 cases. J Thorac surg 1944; 13: 316-339.

Jaretzki Ill A, Penn A, Younger D, Wolff M, Olarte M, Lovelace R. Rowland L. Maximal Thymectomy for myasthenia gravis. J of Thorac and Cardiovasc Surg 1988; 95: 747-57.

Detterbeck F, Scott W, Howard J, Egan T, Keagy B, Starek P, Mill M, Wilcox B. One Hundred Consecutive Thymectoies for Myasthenia Gravis. Ann Thorac surg 1996; 62: 242-245

Hassantash A, Ashbaugh D, Verrier E, Maier R. Surgical treatment of myasthenia gravis in two major Middle East teaching hospitals: factors influencing outcome. Thorax. 1996; 51: 193-196.

Osserman KE. Genkins G. Studies in myasthenia gravis: Review of a twenty-year experience in over 1200 patients. Mt Sinai J Med. 1971 ; 38: 497-537.

Masaoka A. y colrs. Extended thymectomy for Myasthenia Gravis patients: 20 year review. Ann Thorac Surg 1996; 62: 853-859.

Bril V, Kojic J, Werner I, Cooper J. Long-term clinical outcome after transcervical thymectomy for Myasthenia Gravis. Ann Thorac Surg 1998; 65:1520-1522.

Bukley G. y colrs. Extended cervicomediastinal thymectomy in the integrated management of Myasthenia Gravis. Ann of Surg 1997; 226 (3): 324-335.

Lopate G, Pestronk A. Miastenia greve autoinmune. Hospital practice 1993; 8 (6): 5-19.

Stanton E. Myastenia gravis. Henry Ford Hosp Med J 1989; 37(2): 81-85.

Scelsi R. y colrs. Detection and morphology of thymic remnants after video-assisted thoracoscopic extended thymectomy in patients with Myasthenia Gravis. IntSurg 1996; 81:14-17.

Yim A, Kay R, Ho J. Video- assisted thoracoscopic thymectomy for Myasthenia Gravis. Chest. 1995;

Downloads

Published

2000-04-01

How to Cite

Thymectomy for Myasthenia Gravis at Hospital Dr. Rafael. A. Calderon Guardia. (2000). Acta Médica Costarricense , 42(2), 81-85. https://doi.org/10.51481/amc.v42i2.566